Related Experiment Video
Updated: Oct 7, 2025
09:10
Intestinal Epithelial Regeneration in Response to Ionizing Irradiation
Published on: July 27, 2022
2.4K
Retinoic acid for gut health
1Science Signaling, AAAS, Washington, DC 20005, USA.
Science Signaling
|January 11, 2022
Summary
Gut bacteria produce retinoic acid, a crucial molecule that strengthens intestinal epithelial cell defenses. This innate immune priming in mice effectively protects against infection.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- The gut microbiota plays a critical role in host immunity.
- Intestinal epithelial cells form a barrier against pathogens.
- Retinoic acid, a vitamin A derivative, is known to modulate immune responses.
Purpose of the Study:
- To investigate the role of commensal bacteria-derived retinoic acid in innate immunity.
- To determine if retinoic acid primes intestinal epithelial cells against infection.
Main Methods:
- Utilized mouse models to study the gut microbiota and immune responses.
- Analyzed the impact of retinoic acid on intestinal epithelial cell function.
- Assessed protection against enteric pathogen infection.
Main Results:
- Commensal bacteria were found to produce retinoic acid in the gut.
- Retinoic acid treatment enhanced the innate defense mechanisms of intestinal epithelial cells.
- Mice treated with retinoic acid exhibited increased resistance to infection.
Conclusions:
- Commensal-derived retinoic acid is a key factor in bolstering intestinal innate immunity.
- Targeting retinoic acid pathways could be a strategy for preventing or treating gut infections.
Related Concept Videos
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
230
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
230
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
359
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
359
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
444
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
444
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
282
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
282
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
602
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
602
01:17Drugs for Treatment of Diarrhea-Predominant IBS
348
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
348